Thymalin vs Thymosin Alpha-1

Side-by-side comparison of Thymalin, Thymosin Alpha-1 — mechanism, dosing, half-life, side effects, and research status.

← Pick different peptides
Attribute Thymalin Thymalin (Thymic Polypeptide Extract) Longevity Thymosin Alpha-1 Thymosin Alpha-1 (Tα1) Longevity
Basics
Molecular type Thymic Peptide BioregulatorThymic Peptide
Amino acids —28
Molecular weight —3,108.4 Da
Half-life Short (hours)~2 hours
Route(s) Intramuscular, SubcutaneousSubcutaneous
Mechanism & Research
Primary mechanism Thymalin contains a complex mixture of thymic peptides that collectively support T-lymphocyte differentiation, maturation, and functional activation. The primary active components include thymulin, thymosin alpha-1, thym… Thymosin Alpha-1 stimulates T-cell differentiation and maturation, particularly enhancing T-helper cell (Th1) responses. This drives improved cell-mediated immunity — the arm of the immune system responsible for clearing…
Research status Research Compound Research Compound
Evidence summary Thymalin is the thymic component of the pivotal Russian longevity research programme by Khavinson and Anisimov. The 25-year longitudinal studies using Thymalin + Epithalamin represent the most extended human peptide long… Thymosin Alpha-1 has extensive human clinical data from its regulatory approval in Asia and Europe for viral hepatitis and cancer adjunct therapy. Longevity applications build on this established safety and immune-modula…
Protocol & Dosing
Typical dose 10–20 mg per course (typically split across 5–10 injections)1.6 mg per injection (standard clinical dose)
Frequency Daily injections during the course2x per week for 6–12 weeks
Duration 10-day course, twice yearly6–12 weeks
Timing Any timeAny time of day
Safety
Common side effects
  • Injection site pain (IM)
  • Mild flu-like symptoms (immune activation)
  • Fatigue (first few days)
  • Mild fever (rare)
  • Injection site redness
  • Mild flu-like symptoms (first injection)
  • Fatigue (transient)
Contraindications
  • Active autoimmune disease
  • Post-transplant immunosuppression
  • Known bovine/porcine sensitivity
  • Active autoimmune disease (immune stimulation risk)
  • Post-organ transplant (immunosuppression may be reversed)
  • Known allergy to thymic peptides
Anti-doping Not Prohibited Not Prohibited
Deeper reading
Related peptides Thymosin Alpha-1, Epithalon, MOTS-c Epithalon, TB-500, LL-37
Full profile Read full Thymalin profile → Read full Thymosin Alpha-1 profile →

Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.